Status:
RECRUITING
Increasing the Use of an Anti-snoring Mouth Guard (Mandibular Advancement Appliance) to Prevent Upper Airway Collapse During Sleep in Patients With Obstructive Sleep Apnoea.
Lead Sponsor:
Queen Mary University of London
Conditions:
Obstructive Sleep Apnea
Eligibility:
All Genders
40-90 years
Phase:
NA
Brief Summary
Obstructive Sleep Apnoea (OSA) is a sleep-related breathing disorder that is characterized by the repeated collapse of the upper airway during sleep, resulting in sleep deprivation. Mandibular Advance...
Detailed Description
The present study aims to assess whether special support approaches i.e. Interventions influence patients with Obstructive sleep apnoea (OSA), to use the Mandibular Advancement Appliance (MAA) or the ...
Eligibility Criteria
Inclusion
- Adult (≥ 40 years old)
- Confirmed diagnosis of OSA (AHI ≥ 5)
- Referred for MAA therapy
- Must be able to understand, read and write English; with the assistance of a translator
Exclusion
- Insufficient teeth for MAA fabrication
- Poor dental and/or periodontal health
- Symptomatic Temporomandibular Disorder (TMD)
- Previously used an MAA
- Patients with Epilepsy
Key Trial Info
Start Date :
December 6 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT04092660
Start Date
December 6 2019
End Date
March 1 2026
Last Update
May 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal London Dental Hospital
London, United Kingdom, E1 2AD